CT2124/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF INHALED LONG-ACTING BETA 2 AGONIST FOR CHILDREN BETWEEN 4 AND 12 YEARS OF AGE (SALMETEROL OR FORMOTEROL)
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
40 / 100
Risk factors
Structured data indicates isFrameworkAgreement: false, but title includes 'FRAMEWORK CONTRACT'. Also submission time mi...
Award criteria, detailed selection criteria, contract terms, and technical specifications not provided in analyzed data.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- EUR 1.6M estimated value
- Supplies contract
- 1 lot
- Supply of inhaled long-acting beta 2 agonist for children between 4 and 12 years of age (salmeterol or formoterol)
- Single lot framework contract in Malta
Show full summary
Open tender for a framework contract (single lot) for the supply of inhaled long-acting beta 2 agonist for children aged 4-12 years (salmeterol or formoterol) in Malta. Estimated value €1,620,000. Deadline for submissions: 2026-07-13. Only structured notice and XML notice available; procurement documents not analyzed.
Risks
Structured data indicates isFrameworkAgreement: false, but title includes 'FRAMEWORK CONTRACT'. Also submission time mi...
Award criteria, detailed selection criteria, contract terms, and technical specifications not provided in analyzed data.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Tenders must be received by 2026-07-13, 07:30 local time (as per structured data; XML notice indicates 09:30 local time – note inconsistency in time, prefer structured data)
Administrative
- Tenders must be submitted electronically (electronicSubmission: required)
- Submission language: English
Requirements may be incomplete.
Buyer
Name
Department of Contracts
Location
Floriana, MLT
Website
Buyer profile
Identifier
MT25645419
Lots (1)
LOT-0001
CT2124/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF INHALED LONG-ACTING BETA 2 AGONIST FOR CHILDREN BETWEEN 4 AND 12 YEARS OF AGE (SALMETEROL OR FORMOTEROL)
Framework contract for the supply of inhaled long-acting beta 2 agonist (salmeterol or formoterol) for children aged 4 to 12 years.
EUR 1.6M
Estimated value
Location
Category
Deadline
Award details
Value note
Show original TED data
Original TED description
CT2124/2026 - FRAMEWORK CONTRACT FOR THE SUPPLY OF INHALED LONG-ACTING BETA 2 AGONIST FOR CHILDREN BETWEEN 4 AND 12 YEARS OF AGE (SALMETEROL OR FORMOTEROL)
Procurement Details
- Publication date
- 02 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- English
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 380894-2026
- Source notice ID
- 671fd161-db1c-4f60-9395-15f2ef87d1f5
Documents (2)
Similar tenders
Romania – Pharmaceutical products – Furnizare MEDICAMENTE, pe o perioada de 24 luni la Spitalul Orasenesc Gura Humorului
Poland – Medicinal products for the blood, blood-forming organs and the cardiovascular system – Dostawa produktów leczniczych dla krwi, organów krwiotwórczych oraz układu krążenia, toksyn, środków leczniczych dla układu oddechowego, środków przeciwnowotworowych i immunomodulacyjnych stosowanych w ramach programów lekowych i chemioterapii, immunoglobulin oraz środków antywirusowych do użytku ogólnoustrojowego dla SPWSZ w Szczecinie
Malta – Toxins – CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Malta – Toxins – CT2183/2026 - Framework Contract for the supply of Sulphur Hexaflouride 8 microlitres/ml Powder and Solvent for Dispersion for Injection
Hungary – Toxins – K2638 Patkányírtáshoz szükséges irtószerek beszerz
Poland – Medicinal products for the blood, blood-forming organs and the cardiovascular system – Dostawa produktów leczniczych dla krwi, organów krwiotwórczych oraz układu krążenia, toksyn, środków leczniczych dla układu oddechowego, środków przeciwnowotworowych i immunomodulacyjnych stosowanych w ramach programów lekowych i chemioterapii, immunoglobulin oraz środków antywirusowych do użytku ogólnoustrojowego dla SPWSZ w Szczecinie
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
40 / 100
Risk factors
Structured data indicates isFrameworkAgreement: false, but title includes 'FRAMEWORK CONTRACT'. Also submission time mi...
Award criteria, detailed selection criteria, contract terms, and technical specifications not provided in analyzed data.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications